Nexalin Technology, Inc. (NXL)

CIK 0001527352 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
Latest FY-2025 —
Q3-2025 —
FY-2024
Q2-2025 —
Q1-2025 —
FY-2024
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —
Q2-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Condensed Consolidated Statements of Operations and Comprehensive Gain (loss) (unaudited)
—
Consolidated Statements of Operations and Comprehensive Loss
Condensed Consolidated Statements of Operations and Comprehensive Gain (loss) (unaudited) (P)
—
Consolidated Statements of Operations and Comprehensive Loss (P)
Consolidated Statements of Changes In Stockholders' Equity
Consolidated Statements of Changes In Stockholders' Equity (deficit)
Consolidated Statements of Cash Flows
Notes
Accrued Expenses
Award Timing Disclosure
—
Commitments and Contingencies
Concentration of Credit Risk
Cybersecurity Risk Management and Strategy Disclosure
—
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Leases
Liquidity
—
Liquidity and Going Concern
Loans Payable
Nature of The Organization and Business
Non-consolidated Joint Venture and Related Party Transactions
Pay Vs Performance Disclosure
Related Party Transactions
Segment Information
Stockholders Equity
Stockholders Equity (deficit)
Subsequent Events
Subsquent Events
—
Summary of Significant Accounting Policies
—
Summary of Significant Accounting Policies and New Accounting Standards